Healthcare Investor Day 2019

Spark Plus is hosting a Healthcare Investor Day on 19 September 2019. The key management of each company will be presenting on this day and investors will have the opportunity to attend one-on-one meetings with the respective companies of interest.

Three health care and pharmaceuticals companies will be participating, namely Aptorum Group (NASDAQ:APM), Recce Pharmaceuticals (ASX:RCE) and PharmAust Limited (ASX:PAA).

This corporate access day will be joined by over 40 finance professionals from the hedge fund, family offices, institutional and accredited investors based in Singapore.

Agenda:

12.00PM - 12.25 PM - Registration & Lunch begins

12.25PM - 12.30PM - Opening Address by Spark Plus

12.30PM - 12.50PM - Presentation by Aptorum Group (NASDAQ:APM)

12.50PM - 1.10PM - Presentation by PharmAust Limited (ASX:PAA)

1.10PM - 1.30PM - Closing Remarks and Networking

Summary of the companies:

Aptorum Group (NASDAQ:APM)
Market Cap: USD 468m
Description: Aptorum Group is a pharmaceutical company currently in the preclinical stage, dedicated to developing and commercializing a broad portfolio of projects under development of therapeutic and diagnostic technologies to tackle unmet medical needs.
Website: https://www.aptorumgroup.com/

PharmAust Limited (ASX:PAA)
Market Cap: USD 24m
Description: PAA is a clinical-stage company developing targeted cancer therapeutics to address both human and animal healthcare. The company specialises in repurposing marketed drugs lowering the risks and costs of development. These efforts are supported by PAA’s subsidiary, Epichem, which is a highly successful contract medicinal chemistry company that generates significant annual revenues.
Website: https://pharmaust.com/